Sintx Technologies (SINT) Share-based Compensation (2013 - 2026)
Sintx Technologies' (SINT) quarterly Share-based Compensation came in at $530000.0 in Q1 2026, up 2844.44% year-on-year from $18000.0 in Q1 2025, and down 57.84% quarter-over-quarter from $1.3 million in Q4 2025.
Sintx Technologies (SINT) Share-based Compensation (2013 - 2026) Analysis & Trends
Sintx Technologies' Share-based Compensation history runs 14 years deep, the most recent figure standing at $530000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 2844.44% year-over-year to $530000.0 in Q1 2026; TTM through Mar 2026 was $2.1 million, a 4070.0% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 2334.15% from the prior year.
- Share-based Compensation retreated to $530000.0 in Q1 2026 per SINT's latest filing, from $1.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.1 million in Q3 2025 and bottomed at $7000.0 in Q4 2024.
- The 5-year median for Share-based Compensation is $86000.0 (2023), against an average of $288705.9.
- Across the five-year window, Share-based Compensation plunged 89.55% in 2024 and jumped 20710.0% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $89000.0 in 2022, then fell by 24.72% to $67000.0 in 2023, then plunged by 89.55% to $7000.0 in 2024, then surged by 17857.14% to $1.3 million in 2025, then plunged by 57.84% to $530000.0 in 2026.
- Per Business Quant, the three latest SINT Share-based Compensation figures stand at $530000.0 (Q1 2026), $1.3 million (Q4 2025), and $2.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Sintx Technologies | 5.66 Mn | 3.77 Mn | 144,000.00 | 530,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 530,000.00 |
| Mar 31, 2026 | 530,000.00 |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 280,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Dec 31, 2023 | 67,000.00 |